You have lost 25% in two days with your Sell ZIOP and Buy CRMD trade recommendation:
CRMD has dropped 14% in two days since your mid-day Buy at $1.05 that is now $0.95.
ZIOP has climbed 11% in two days since your mid-day Sell at $2.38 that is now $2.65.
im surprised that it's only gone down since they got their CE mark. i guess it's as people say "sell on the news". but, i agree, they should do well once they get sales going... or even get bought by a big fish.
Agree. Synthetic bio is just new name for gene therapy. no real data from ziop or intrexon in how it can benefit cancer patients. is their il-12 any better than the old fashioned il-12 therapy? we have to wait for not just phase 2 but also phase 3. They did show promise with pali in phase 2 and failed in phase 3.
thats true only 15/30 patients in pii il12 melanoma are in the high dose group which is the only therapeutic group and it will finish enrollment in about six months then topline another six to nine months so 12-15 months for topline
interestingly someone suggested oncosec could get accelerated approval with their all high dose 24 patient phase ii but its questionable...still that would rocket their valuation to insane heights